Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Københavns Universitets forskningsportal Forside
Hjælp og OSS
Dansk
English
Forside
Profiler
Publikation
Forskningsenheder
Presse/medier
Aktiviteter
Priser
???studenttheses???
Forskningsdatasæt
Søg efter ekspertise, navn eller tilknytning
Glucagon-Like Peptide 1: A Predictor of Type 2 Diabetes?
Matthias Ploug Larsen,
Signe Sørensen Torekov
Biomedicinsk Institut
Endocrinology and Metabolism
10
Citationer (Scopus)
45
Downloads (Pure)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'Glucagon-Like Peptide 1: A Predictor of Type 2 Diabetes?'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Glucagon-like
100%
Glucagon-like peptide-1 (GLP-1)
100%
Impaired Fasting Glucose
66%
Impaired Glucose Tolerance
66%
Pre-diabetes (pre-DM)
33%
PubMed Database
11%
Diabetes
11%
Type 2 Diabetic Patients
11%
Glucagon
11%
Broad Search
11%
Measurement Techniques
11%
Large Sample Size
11%
Non-esterified Fatty Acids
11%
Incretin Hormones
11%
Longitudinal Prospective Study
11%
Incretin Effect
11%
Metformin
11%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Glucagon Like Peptide 1
100%
Impaired Glucose Tolerance
80%
Impaired Fasting Glucose
60%
Incretin
20%
Glucagon
10%
Prospective Study
10%
Body Mass Index
10%
Patient with Type 2 Diabetes
10%
Measurement Technique
10%
Diabetes
10%
Fatty Acid
10%
Glycon
10%
Secretion (Process)
10%
Nursing and Health Professions
Glucagon Like Peptide 1
100%
Non Insulin Dependent Diabetes Mellitus
100%
Impaired Glucose Tolerance
80%
Incretin
20%
Fatty Acid
10%
Patient with Type 2 Diabetes
10%
Glucagon
10%
Medline
10%
Metformin
10%
Sample Size
10%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Glucagon-Like Peptide-1
100%
Impaired Glucose Tolerance
80%
Incretin
20%
Fatty Acid
10%
Glucagon
10%
Metformin
10%
Prospective Study
10%
Biochemistry, Genetics and Molecular Biology
Glucagon-Like Peptide-1
100%
Impaired Glucose Tolerance
80%
Incretin
20%
Prospective Study
10%
Glucagon
10%
Medline
10%
Sample Size
10%
Secretion (Process)
10%